Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Neurology  |  Family Medicine

Search Medical Condition
Please enter condition
Please choose location
Clear Trial Filters
 

Alzheimer's Disease Clinical Trials

A listing of Alzheimer's Disease medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (53) clinical trials

Parkinson’s disease affects about 1 million people in the United States. Up to 50% of those affected experience daily changes in performing motor activities, called “OFF” episodes. These include periods of time where your medication wears off before the next dose and your Parkinson’s disease symptoms return, a delay in ...

Phase

NeuroTrials Research is conducting a study to examine the effect of an investigational drug on sleep quality in patients with mild Alzheimer's Disease and cognitive impairment. All study-related care and study drug will be provided at no cost. Qualified participants and caregivers will be compensated for time and travel. Patient ...

Phase

The primary objective of the study is to evaluate the efficacy of monthly doses of Aducanumab in slowing cognitive and functional impairment.

Phase

This is a study that will include subjects with mild cognitive impairment and early Alzheimer's disease. Eligible subjects will received the investigational medication or placebo monthly through an IV infusion for 18 months and will then be able to go into a 2 year open label study where all subjects ...

Phase

This clinical trial is provided by TrialReach. Researchers have recently begun testing the idea that patients with early Alzheimer's disease are more likely to benefit from treatment than those with more advanced disease. This study is testing how well a potential new treatment works to reverse the symptoms of early ...

Phase

This clinical trial is provided by TrialReach. Researchers have recently begun testing the idea that patients with early Alzheimer's disease are more likely to benefit from treatment than those with more advanced disease. This study is testing how well a potential new treatment works to reverse the symptoms of early ...

Phase

This Phase III study is designed as a randomized, double-blinded, placebo-controlled study for subjects with evidence of early AD. The study will evaluate safety and tolerability, efficacy as measured by CDR-SB, and will determine if the combination therapy ALZT-OP1 will slow down, arrests, or reverse cognitive and functional decline in ...

Phase

Alzheimer’s disease (AD) is the most common cause of dementia. The deposition of extracellular amyloid plaques in the brain is a hallmark pathological finding in AD. These amyloid plaques are primarily composed of Aβ peptides. This study is to evaluate crenezumab, a monoclonal antibody, that has been shown to inhibit ...

Phase